KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Common Equity (2016 - 2025)

Historic Common Equity for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $4.4 billion.

  • Globus Medical's Common Equity rose 809.53% to $4.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 billion, marking a year-over-year increase of 809.53%. This contributed to the annual value of $4.2 billion for FY2024, which is 448.66% up from last year.
  • Globus Medical's Common Equity amounted to $4.4 billion in Q3 2025, which was up 809.53% from $4.3 billion recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's Common Equity peaked at $4.4 billion during Q3 2025, and registered a low of $1.6 billion during Q1 2021.
  • Moreover, its 5-year median value for Common Equity was $2.0 billion (2023), whereas its average is $2.9 billion.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 13735.95% in 2023, then tumbled by 281.54% in 2024.
  • Over the past 5 years, Globus Medical's Common Equity (Quarter) stood at $1.7 billion in 2021, then increased by 6.03% to $1.8 billion in 2022, then soared by 116.53% to $4.0 billion in 2023, then increased by 4.49% to $4.2 billion in 2024, then increased by 5.3% to $4.4 billion in 2025.
  • Its last three reported values are $4.4 billion in Q3 2025, $4.3 billion for Q2 2025, and $4.1 billion during Q1 2025.